Early treatment with FCR versus watch and wait in patients with stage Binet A highrisk chronic lymphocytic leukemia CLL a randomized phase 3 trial

Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial

12:19 EST 19 Feb 2020 | Nature Publishing

More From BioPortfolio on "Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial"